In conclusion, ESM enhances the secretion of antifibrosis mediator DCN from fibroblasts, ameliorates BLM-induced pulmonary fibrosis, and suppresses the TGF-β-dependent fibrosis signaling pathway TAZ in vitro and in vivo. Here, TGFB1 is linked to pulmonary fibrosis.